Registration number:
BSN (SW) Limited
for the Year Ended 31 January 2025
BSN (SW) Limited
(Registration number: 10373052)
Balance Sheet as at 31 January 2025
|
Note |
2025 |
2024 |
|
|
Fixed assets |
|||
|
Intangible assets |
|
|
|
|
Tangible assets |
|
|
|
|
|
|
||
|
Current assets |
|||
|
Stocks |
|
- |
|
|
Debtors |
|
|
|
|
Cash at bank and in hand |
|
|
|
|
|
|
||
|
Creditors: Amounts falling due within one year |
( |
( |
|
|
Net current assets |
|
|
|
|
Total assets less current liabilities |
|
|
|
|
Creditors: Amounts falling due after more than one year |
( |
( |
|
|
Provisions for liabilities |
( |
( |
|
|
Net assets |
|
|
|
|
Capital and reserves |
|||
|
Called up share capital |
100 |
100 |
|
|
Retained earnings |
263,215 |
207,070 |
|
|
Shareholders' funds |
263,315 |
207,170 |
BSN (SW) Limited
(Registration number: 10373052)
Balance Sheet as at 31 January 2025
For the financial year ending 31 January 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
|
• |
|
|
• |
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
Approved and authorised by the
|
|
BSN (SW) Limited
Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025
|
General information |
The company is a private company limited by share capital, incorporated in England and Wales..
The address of its registered office is:
These financial statements were authorised for issue by the
|
Accounting policies |
Summary of significant accounting policies and key accounting estimates
The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).
Basis of preparation
These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.
The financial statements are prepared in sterling, which is the functional and presentational currency of the company, and rounded to the nearest £.
Revenue recognition
Turnover represents amounts chargeable in respect of the sale of goods and services net of value added tax.
Goods sold are recognised upon the completion of the transaction on the delivery of the goods.
Hire sales are recognised straight line over the term of the lease agreements.
Government grants
Government grants are recognised when it is reasonable to expect that the grants will be received
and that all related conditions will be met, usually on submission of a valid claim or payment.
Government grants in respect of capital expenditure are credited to a deferred income account and
are released to profit over the expected useful lives of the relevant assets by equal annual
instalments.
Grants of a revenue nature are credited to income so as to match them with the expenditure to which
they relate.
BSN (SW) Limited
Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025
Tax
The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.
The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.
Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.
Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.
Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.
Tangible assets
Tangible assets are stated in the Balance Sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.
Depreciation
Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:
|
Asset class |
Depreciation method and rate |
|
Office equipment |
25% straight line |
|
Motor vehicles |
25% reducing balance |
Goodwill
Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.
Intangible assets
Other Intangibles assets are recognised initially at cost which is normally the transaction price excluding transaction costs. Subsequently, they are measured at fair value through the profit and loss when they can otherwise be measured reliably.
BSN (SW) Limited
Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025
Amortisation
Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:
|
Asset class |
Amortisation method and rate |
|
Other investments |
Remeasured to fair value at each reporting date |
|
Other intangible assets |
Not amortised as the residual value exceeds the cost. |
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.
The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.
Share capital
Dividends and other distributions to the equity holders of the company are recognised as a liability in the statement of changes in equity in the period in which the dividend and other distributions are approved by the shareholders.
Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.
|
Staff numbers |
The average number of persons employed by the company (including directors) during the year was
BSN (SW) Limited
Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025
|
Intangible assets |
|
Other investments |
Other intangible assets |
Total |
|
|
Cost or valuation |
|||
|
At 1 February 2024 |
|
|
|
|
Revaluations |
( |
- |
( |
|
At 31 January 2025 |
- |
|
|
|
Amortisation |
|||
|
Carrying amount |
|||
|
At 31 January 2025 |
- |
|
|
|
At 31 January 2024 |
|
|
|
The director has assessed the valuation of the other investments and considers that the market value as at 31 January 2025 is £nil (2024: £435)
BSN (SW) Limited
Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025
|
Tangible assets |
|
Office equipment |
Motor vehicles |
Total |
|
|
Cost or valuation |
|||
|
At 1 February 2024 |
|
|
|
|
Additions |
- |
|
|
|
Disposals |
( |
- |
( |
|
At 31 January 2025 |
|
|
|
|
Depreciation |
|||
|
At 1 February 2024 |
|
|
|
|
Charge for the year |
|
|
|
|
Eliminated on disposal |
( |
- |
( |
|
At 31 January 2025 |
|
|
|
|
Carrying amount |
|||
|
At 31 January 2025 |
|
|
|
|
At 31 January 2024 |
|
|
|
|
Stocks |
|
2025 |
2024 |
|
|
Other inventories |
|
- |
|
Debtors |
|
2025 |
2024 |
|
|
Trade debtors |
|
|
|
Other debtors |
|
|
|
|
|
BSN (SW) Limited
Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025
|
Creditors |
|
Due within one year |
Note |
2025 |
2024 |
|
Loans and borrowings |
|
|
|
|
Trade creditors |
|
|
|
|
Social security and other taxes |
|
|
|
|
Other creditors |
|
|
|
|
Accruals |
|
|
|
|
Corporation tax liability |
27,588 |
104,876 |
|
|
|
|
||
|
Due after one year |
|||
|
Loans and borrowings |
|
|
|
Loans and borrowings |
Current loans and borrowings
|
2025 |
2024 |
|
|
Bank borrowings |
|
|
|
Hire purchase contracts |
|
|
|
|
|
|
Hire purchase contracts are secured against the assets to which they relate.
Non-current loans and borrowings
|
2025 |
2024 |
|
|
Bank borrowings |
|
|
|
Hire purchase contracts |
|
|
|
|
|
|
Hire purchase contracts are secured against the assets to which they relate.
|
Related party transactions |
Included in other debtors due within one year are loans advanced to related companies amounting to £224,434 (2024: £176,755). The loans are interest free and repayable on demand.
The company is a third party guarantee in respect of a loan between Barclays Bank and a related company. The guarantee is in the form of a fixed and floating charge over the assets of the company.
BSN (SW) Limited
Notes to the Unaudited Financial Statements for the Year Ended 31 January 2025
Loans to related parties
|
2025 |
Key management |
Total |
|
Advanced |
|
|
|
Repaid |
( |
( |
|
At end of period |
- |
- |
|
|
||
|
2024 |
Key management |
Total |
|
Advanced |
|
|
|
Repaid |
( |
( |
|
At end of period |
- |
- |
|
|
||
Terms of loans to related parties